Lin Gao

Synthesis and Biological Evaluation of Novel Bouchardatine Derivatives as Potential Adipogenesis/Lipogenesis Inhibitors for Antiobesity Treatment.

Ji-Ming Ye, Ding Li, Yong Rao, 2015, Journal of medicinal chemistry.

Natural alkaloid bouchardatine ameliorates metabolic disorders in high‐fat diet‐fed mice by stimulating the sirtuin 1/liver kinase B‐1/AMPK axis

Yong Rao, Zhishu Huang, L. Gu, 2017, British journal of pharmacology.

Discovery of natural alkaloid bouchardatine as a novel inhibitor of adipogenesis/lipogenesis in 3T3-L1 adipocytes.

Yong Rao, Zhishu Huang, Tian-Miao Ou, 2015, Bioorganic & medicinal chemistry.

Bouchardatine analogue alleviates non‐alcoholic hepatic fatty liver disease/non‐alcoholic steatohepatitis in high‐fat fed mice by inhibiting ATP synthase activity

Yong Rao, Chan Li, Yao-Hao Xu, 2019, British journal of pharmacology.

Bouchardatine analogue alleviates NAFLD/NASH in high fat fed mice via blunting ATP synthase activity.

Yong Rao, Chan Li, Yao-Hao Xu, 2019, British journal of pharmacology.

Design, synthesis and biological evaluation of novel bouchardatine analogs as potential inhibitors of adipogenesis/lipogenesis in 3T3-L1 adipocytes.

Yong Rao, Yao-Hao Xu, Yu-Tao Hu, 2018, European journal of medicinal chemistry.